M&G PLC

Position in JNJ — Johnson & Johnson

CIK 1802539 London, X0

Position in JNJ

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$13,334,694

-$5,245,434 QoQ

Shares Held

52,505

-30.9% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#947

of 4,676 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

M&G PLC holds $1,479,850,248 across 11 Drug Manufacturers - General names. JNJ ranks #6 (0.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AZN	Astrazeneca PLC	4,482,712	$850,011,848
2	BMY	Bristol Myers Squibb Co	5,292,229	$304,938,234
3	ABBV	AbbVie Inc.	579,447	$145,812,043
4	AMGN	Amgen Inc	289,819	$104,949,256
5	MRK	Merck & Co., Inc.	210,965	$27,109,002
6	JNJ	Johnson & Johnson This page	52,505	$13,334,694
7	PFE	Pfizer Inc	418,626	$10,080,514
8	GILD	Gilead Sciences, Inc.	78,527	$9,921,101

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$13,334,694	52,505	-30.9%	Shares	Defined	2026-08-06
2026-03-31	$18,580,128	76,011	-3.5%	Shares	Defined	2026-05-13
2025-12-31	$16,296,691	78,747	-0.2%	Shares	Defined	2026-02-12
2025-09-30	$14,627,598	78,889	-40.3%	Shares	Defined	2025-11-07
2025-06-30	$20,187,440	132,160	-38.9%	Shares	Sole	2025-08-08
2025-03-31	$35,897,228	216,457	-17.4%	Shares	Sole	2025-05-13
2024-12-31	$37,916,616	262,181	-5.5%	Shares	Sole	2025-02-11
2024-09-30	$44,950,096	277,367	-3.8%	Shares	Sole	2024-10-31
2024-06-30	$42,136,320	288,289	+47.4%	Shares	Sole	2024-07-16
2024-03-31	$30,930,416	195,527	—	Shares	Sole	2024-05-10
No filing history on record for this holder in this stock.